ロード中...
Model‐Based Comparison of Dose‐Response Profiles of Tofacitinib in Japanese Versus Western Rheumatoid Arthritis Patients
Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). The aim of this analysis was to characterize the relationship between tofacitinib dose and efficacy, as measured by American College of Rheumatology (ACR) response rates, and to compare this between Japanes...
保存先:
| 出版年: | J Clin Pharmacol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6972659/ https://ncbi.nlm.nih.gov/pubmed/31512746 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1514 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|